The Pennsylvania Department of Health announcedthe Medical Marijuana Program has exceeded five million dispensing events. The program has also recently operationalized two clinical registrants to participate in the medical marijuana research program, bringing the total number of operational clinical registrants to three.
“Pennsylvania’s medical marijuana program continues to be a leader for the country in terms of program growth and the first in the nation research program,” Secretary of Health Dr. Rachel Levine said. “Operationalizing the clinical registrants partnered with three of our academic clinical research centers is essential to providing physicians with more evidence-based research to make clinical decisions for their patients. This is the cornerstone of our program and the key to our clinically-based, patient-focused program for those suffering with cancer, PTSD and other serious medical conditions.”
At the end of April, the state’s first clinical registrant, MLH Explorations, LLC was operationalized. MLH Explorations, LLC is partnered with the Sidney Kimmel Medical College at Thomas Jefferson University.
Within the last week, the program operationalized our second and third clinical registrants, Organic Remedies, Inc., partnered with the Philadelphia College of Osteopathic Medicine and PA Options for Wellness, Inc., partnered with Penn State College of Medicine.
The clinical research program, guided by Act 43 of 2018, allows for eight clinical registrants who each must hold both a grower/processor and a dispensary permit. Clinical registrants must have a research contract with one of eight approved academic clinical research centers.
Three clinical registrants were approved in June 2019, with four additional clinical registrants approved in February of 2020. Applications for the remaining clinical registrant are currently being reviewed.
There are close to 205,000 active certifications as part of the medical marijuana program. Nearly 356,000 patients and caregivers are registered for the program in order to obtain medical marijuana for one of 23 serious medical conditions.
There are currently 87 operational dispensaries in the commonwealth providing medication to patients. Active cardholders are continuing to visit dispensaries more than once a month to get treatment for a serious medical condition. More than 14 million products have been sold since the start of the program, and total sales within the program are over $1 billion, which includes sales by the grower/processors to the dispensaries, and sales by the dispensaries to patients and caregivers.